Researchers Publish Final Results of Key Clinical Trial for Monoclonal Antibody in Young Children With Eosinophilic Esophagitis
June 29, 2024
June 29, 2024
PHILADELPHIA, Pennsylvania, June 29 (TNSres) -- Children's Hospital of Philadelphia issued the following news:
An international team of researchers including several at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial that led to the approval of the monoclonal antibody dupilumab for the treatment of pediatric patients between the ages of 1 and 11 years old with eosinophilic esophagitis (EoE) by the U.S. Food and Drug Administra . . .
An international team of researchers including several at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial that led to the approval of the monoclonal antibody dupilumab for the treatment of pediatric patients between the ages of 1 and 11 years old with eosinophilic esophagitis (EoE) by the U.S. Food and Drug Administra . . .